Who Should Attend
- Primary Care Physicians
- Specialty Physicians
- Nurses
- Nurse Practitioners
- Pharmacists
- Physician Assistants
- Psychologists
Learning Objectives
Upon completion of this activity, participants will be able to:
- Demonstrate the optimal management of oligometastatic prostate, bladder, renal cancer
- Explain the role of immunotherapy in the management of bladder, prostate and renal cancer
- Determine how to incorporate genomic classifiers, multiple parametric MRI, and clinical parameters into selecting optimal patients with prostate cancer for active surveillance or other definitive management approaches
- Apply Level 1 evidence on the use of novel treatment paradigms and updated surveillance options for patients with prostate, renal, bladder, or testicular cancer
- Apply novel minimally invasive treatments for GU malignancies including prostate, bladder and kidney cancer
- Use multiparametric MRI, fusion biopsy and novel markers in men at risk for prostate cancer
- Biennial Course in Urologic Oncology
THURSDAY, OCTOBER 13, 2022
7:15 – 8:00 AM
Registration
8:00 – 8:05 AM
Welcome
Anthony D’Amico
8:05 – 8:20 AM
Epidemiology and Genetics
Lorelei Mucci
8:20 – 8:35 AM
Screening in 2022: Role of PSA and Novel Biomakers
Adam Kibel
8:35 – 8:50 AM
Advanced in Multiparametric MRI for Diagnosis and Staging
Clare Tempany
8:50 – 9:05 AM
Interpreting Prostrate Biopsy Reports
Michelle Hirsch
9:05 – 9:30 AM
Expert Panel: Screening and Diagnosis
Moderator: Anthony D’Amico
Speakers: Michelle Hirsch, Adam Kibel, Lorelei Mucci and Clare Tempany
9:30 – 10:00 AM
Break
10:00 – 10:15 AM
Focal Ablation and Active Surveillance in Intermediate Risk Disease
Alexander Cole
10:15 – 10:30 AM
Radical Prostatectomy in Intermediate Risk Disease
Quoc-Dien Trin
10:30 AM – 10:45 AM
Hypofractionation and ADT use in Intermediate Risk Prostate Cancer
Neil Martin
10:45 – 11:00 AM
MRI Guided Radiation therapy
Jonathan Leeman
11:00 – 11:15 AM
Optimizing Systemic Therapy in the Management of Intermediate and High-Risk Prostate Cancer
Anthony D’Amico
11:15 – 11:30 AM
Novel Approaches in the Preoperative Setting for the High-Risk Patient
Mary-Ellen Taplin
11:30 – 11:45 AM
Biomarker Based Clinical Trials and Prostate Cancer
Martin Gleave
11:45 AM – 12:15 PM
Expert Panel: Patient Selection
Moderator: Anthony D’Amico
Speakers: Alexander Cole, Martin Gleave, Jonathan Leeman, Neil Martin, Mary-Ellen Taplin, Quoc-Dien Trinh
12:15 – 1:00 PM
Lunch
1:00 – 1:15 PM
PET Imaging in the PSA Recurrent Setting-Diagnostics
Heather Jacene
1:15 – 1:30 PM
Treatment of Oligo Metastatic Disease, Integration of Surgery
Speaker: Martin Gleave
1:30 – 1:45 PM
Treatment of Oligo Metastatic Disease, Integration of Radiation
Paul Nguyen
1:45 – 2:00 PM
Precision Medicine in Prostate Cancer
Himisha Beltran
2:00 – 2:30 PM
Expert Panel: Updates in Diagnostics and Special Populations
Moderator: Adam Kibel
Speakers: Himisha Beltran, Martin Gleave, Heather Jacene and Paul Nguyen
2:30 – 2:45 PM
Break
2:45 – 3:00 PM
Adjuvant versus Salvage Radiation
Anthony D’Amico
3:00 – 3:15 PM
Management of the Rising PSA in the Patient with M0 Castrate Sensitive Prostate Cancer
Charles Ryan
3:15 – 3:30 PM
Management of Advanced Prostate Cancer in the Elderly
Alicia Morgans
3:30 – 3:45 PM
Survivorship and Side effects of ADT
Phil Saylor
3:45 – 4:00 PM
Management of Side Effects of Radical Prostatectomy in the Denovo and Recurrent Settings
Peter Chang
4:00 – 4:15 PM
Management of Side Effects of Radiation Therapy in the Denovo and Recurrent Settings
Daniel Schmidt
4:15 – 4:30 PM
Management of the Side Effects of Non-ADT Systemic Treatment for Prostate Cancer
Mark Pomerantz
4:30 – 5:00 PM
Expert Panel: Management of Treatment Related Toxicity and Recurrent Disease
Moderator: Adam Kibel
Speakers: Peter Chang, Anthony D’Amico, Alicia Morgans, Mark Pomerantz, Charles Ryan, Phil Saylor and Daniel Schmidt
FRIDAY, OCTOBER 14, 2022
8:00 AM – 8:15 AM
Management of the Rising PSA in the Patient with M0 Castrate Resistant Prostate Cancer
Atish Choudhury
8:15 – 8:30 AM
Personalizing Treatment Selection in Metastatic, Hormone-sensitive Prostate Cancer
Christopher Sweeney
8:30 – 8:45 AM
Immunotherapy for Prostate Cancer
Xiao Wei
8:45 – 9:00 AM
Novel Androgen Receptor Targeted therapy of Castrate Resistant M1 PC
9:00 – 9:15 AM
PET Imaging in the PSA Recurrent Setting – Therapeutics
Praful Ravi
9:15 – 9:45 AM
Expert Panel: Management of Metastatic Prostate Cancer
Moderator: Glenn Bubley
Speakers: Atish Choudhury, Praful Ravi, Charles Ryan, Christopher Sweeney, and Xiao Wei
9:45 – 10:15 AM
Break
10:15 – 10:45 AM
Special Lecture, Kidney Development and Wilms Tumor: Prospects for Regeneration
George Daley
10:45 – 11:00 AM
Role of Biomarkers in Diagnosis and Follow-up
Adam Feldman
11:00 – 11:15 AM
Management of Superficial Bladder Cancer
Angela Smith
11:15 – 11:30 AM
Genomics and its Role in the Management of Bladder Cancer
Joaquim Bellmunt
11:30 – 11:45 AM
Management of Upper Tract Disease
Matthew Mossanen
11:45 AM – 12:00 PM
Urinary Diversion after Cystectomy, Choices and Outcomes
Andrew Wagner
12:00 – 12:15 PM
Lymph Node Dissection and Approaches to Radical Cystectomy
Mark Preston
12:15 – 1:00 PM
Lunch
1:00 – 2:00 PM
Judah Folkman Lecture: Emerging Strategies in the Fight Against Covid-19
Lindsey Baden
2:00 – 2:15 PM
Genomic Predictors of Response to Chemotherapy
Kent Mouw
2:15 – 2:30 PM
Personalizing Bladder Cancer Treatment in Variant Histology
Angela Smith
2:30 – 2:45 PM
Neoadjuvant and Adjuvant Chemotherapy
Richard Lee
2:45 – 3:00 PM
Bladder Sparing Approaches
Jason Efstathiou
3:00 – 3:15 PM
Chemo and Immunotherapy for Advanced Urothelial Cancer
Joaquim Bellmunt
3:15 – 3:45 PM
Expert Panel: Bladder Cancer
Moderator: Adam Kibel
Speakers: Joaquim Bellmunt, Jason Efstathiou, Adam Feldman, Richard Lee, Kent Mouw, Matthew Mossanen, Mark Preston, Angela Smith and Andrew Wagner
3:45 PM – 4:00 PM
Break
4:00 – 4:15 PM
Management of Seminoma
Alok Tewari
4:15 – 4:30 PM
Management of Stage I non-seminoma
Timothy Clinton
4:30 – 4:45 PM
Updates in Radiation Therapy in Testis Cancer
Sophia Kamran
4:45 – 5:00 PM
Management of Advanced Disease-Chemotherapy
Christopher Sweeney
5:00 – 5:15 PM
Emerging Role of Genomics in Testis Cancer
Eliezer Van Allen
5:15 – 5:45 PM
Expert Panel: Testis Cancer
Moderator: Jerome Richie
Speakers: Timothy Clinton, Sophia Kamran, Christopher Sweeney, Alok Tewari and Eliezer Van Allen
SATURDAY, OCTOBER 15, 2022
8:00 – 8:15 AM
Tackling Tumor Metabolism in Renal Cell Carcinoma
Kimryn Rathmell
8:15 – 8:30 AM
Updated in the Pathology Classification of Renal Cell Cancer
Michelle Hirsch
8:30 – 8:45 AM
Role of Observation and Ablation for Small Renal Mass
Aria Olumi
8:45 – 9:00 AM
Radical or Partial Nephrectomy: Techniques and Innovations
Steven Chang
9:00 – 9:15 AM
Managing the Primary when Metastatic and Metastatectomy
Keyan Salari
9:15 – 9:30 AM
Adjuvant Strategies in RCC
Toni Choueiri
9:30 – 10:00 AM
Break
10:00 – 10:15 AM
Advanced Disease: First Line Options
Vincent Xu
10:15 – 10:30 AM
Advanced Disease: Post IO Setting
David McDermott
10:30 – 10:45 AM
Non Clear Cell RCC
Bradley McGregor
10:45 – 11:00 AM
Novel Targets Beyond Targeted Agents and IO Drugs
Xin Gao
11:00 AM – 12:00 PM
Expert Panel: Renal Cell Carcinoma
Moderator: Tonu Choueiri
Speakers: Steven Chang, Xin Gao, Michelle Hirsch, David McDermott, Bradley McGregor, Aria Olumi, Kimryn Rathmell, Keyan Salari and Vincent Xu
